ReviewBMJ global health2021
Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine.
Review in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis.Frontiers in public health · 2022Pooled it
- Strategic solidarity: solidarity and self-interest in Scandinavian contributions to global Covid-19 vaccine equity.Globalization and health · 2026Article
- TRIPS flexibilities help change policy and practice to increase access to medicines: evidence from 2001 to 2024.BMJ global health · 2026Article
- Cinemeducation: a descriptive mixed-methods analysis of perspectives in a medical humanities course.Medical education online · 2025Article
- Overcoming barriers to medical countermeasures: Strengthening global biosecurity.Human vaccines & immunotherapeutics · 2025Review
- Accountability Reimagined: Decolonizing Global Health Through Virtue and Subsidiarity.Health and human rights · 2025Article
- Artificial intelligence, intellectual property, and human rights: mapping the legal landscape in European health systems.npj health systems · 2025Article
- Decolonizing global health: a scoping review of its key components, proposed actions, and contributors.Global health research and policy · 2025Article
- Advancements and challenges in next-generation mRNA vaccine manufacturing systems.Clinical and experimental vaccine research · 2025Review
- Decolonizing global health: a scoping review.BMC health services research · 2025Article
- Transforming trade for vaccine equity: Policy gaps and barriers.PLOS global public health · 2025Article
- Negotiation of new international health law on intellectual property, technology transfer, open science and pathogen access and benefit sharing: a textual and contextual analysis.BMJ public health · 2024Article
- Missing in action: a scoping review of gender as the overlooked component in decolonial discourses.BMJ global health · 2024Article
- Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.Globalization and health · 2024Article
- Colonialism in the new digital health agenda.BMJ global health · 2024Review
- The ethics of knowledge sharing: a feminist examination of intellectual property rights and open-source materials in gender transformative methodologies.Frontiers in research metrics and analytics · 2024Article
- COVAX - Time to reconsider the strategy and its target.Health policy OPEN · 2023Article
- Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity.BMJ global health · 2023Review
- Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen.NPJ vaccines · 2023Article
- A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review.BMJ global health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recent rapid development of COVID-19 vaccines offers hope in addressing the worst pandemic in a hundred years. However, many countries in the Global South face great difficulties in accessing vaccines, partly because of restrictive intellectual property law. These laws exacerbate both global and domestic inequalities and prevent countries from fully realising the right to health for all their people. Commodification of essential medicines, such as vaccines, pushes poorer countries into extreme debt and reproduces national inequalities that discriminate against marginalised groups. This article explains how a decolonial framing of human rights and public health could contribute to addressing this systemic injustice. We envisage a human rights and global health law framework based on solidarity and international cooperation that focuses funding on long-term goals and frees access to medicines from the restrictions of intellectual property law. This would increase domestic vaccine production, acquisition and distribution capabilities in the Global South.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.